🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07584213
Active, not recruiting Observational

The Association Between Blood Routine Parameters and Breast Cancer Prognosis

NCT07584213 · tracked via the Priya Life Science China tracker
Sponsor
Wenjin Yin
Phase
Observational
Started
2026-05-01
Last updated
2026-05-13

Condition(s) studied

Breast Cancer Invasive

Investigational drug(s) / intervention(s)

blood routine test

blood routine test: blood routine test at baseline

Study summary

This is a real-world multicentre study to investigate the association between blood routine parameters combined with clinicopathological characteristics and breast cancer prognosis.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Aged 18 years or older * Pathologically confirmed invasive primary breast cancer Exclusion Criteria: * De novo stage IV breast cancer

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai China

More Wenjin Yin trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07584213 on ClinicalTrials.gov ↗ ← All trials in China